The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 12, 2020

Filed:

Feb. 01, 2018
Applicant:

Pulse Therapeutics, Inc., St. Louis, MO (US);

Inventors:

Francis M. Creighton, Richmond Heights, MO (US);

Michael E. Sabo, Prairie du Rocher, IL (US);

Gerard Epplin, Des Peres, MO (US);

Christopher Null, Crystal City, MO (US);

James Christopher Wachtman, Webster Groves, MO (US);

Assignee:

Pulse Therapeutics, Inc., St. Louis, MO (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 17/22 (2006.01); H01F 7/02 (2006.01); A61M 37/00 (2006.01); A61K 41/00 (2020.01); A61B 17/3207 (2006.01); B82Y 5/00 (2011.01); A61B 17/00 (2006.01); A61B 17/32 (2006.01);
U.S. Cl.
CPC ...
A61B 17/22012 (2013.01); A61B 17/22004 (2013.01); A61B 17/3207 (2013.01); A61K 41/0028 (2013.01); A61M 37/00 (2013.01); H01F 7/0226 (2013.01); H01F 7/0273 (2013.01); A61B 17/22 (2013.01); A61B 17/32002 (2013.01); A61B 2017/00345 (2013.01); A61B 2017/00876 (2013.01); A61B 2017/22084 (2013.01); A61B 2017/320004 (2013.01); A61M 2037/0007 (2013.01); B82Y 5/00 (2013.01); Y10S 977/811 (2013.01); Y10S 977/905 (2013.01); Y10S 977/909 (2013.01);
Abstract

Some embodiments provide a system for external manipulation of magnetic nanoparticles in vasculature using a remotely placed magnetic field-generating stator. In one embodiment, the systems and methods relate to the control of magnetic nanoparticles in a fluid medium using permanent magnet-based or electromagnetic field-generating stator sources. Such a system can be useful for increasing the diffusion of therapeutic agents in a fluid medium, such as a human circulatory system, which can result in substantial clearance of fluid obstructions, such as vascular occlusions, in a circulatory system resulting in increased blood flow. Magnetic nanoparticles are provided having a non-specialized chemical coating facilitating association with a chemical composition by a user before infusion. Systems are provided for delivering a consistent infusion mass of magnetic nanoparticles to a patient.


Find Patent Forward Citations

Loading…